Načítá se...
‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’
PURPOSE: To evaluate the efficacy/safety of ‘tamsulosin and darifenacin’ (TD) vs. ‘tamsulosin and placebo’ (TP) for patients with symptomatic benign prostrate hyperplasia (BPH) with accompanying overactive bladder (OAB) symptoms. MATERIALS AND METHODS: This study included symptomatic patients of BPH...
Uloženo v:
| Vydáno v: | J Clin Diagn Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
JCDR Research and Publications (P) Limited
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4525548/ https://ncbi.nlm.nih.gov/pubmed/26266159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2015/12526.6019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|